Lebanon, NH, United States of America

Margaret Ackerman

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Margaret Ackerman

Introduction

Margaret Ackerman is a prominent inventor based in Lebanon, NH (US), known for her significant contributions to the field of biomedical research. With a total of 3 patents, she has made strides in developing methods and compositions that address critical health issues.

Latest Patents

Among her latest patents is a groundbreaking work titled "Compositions and methods for preventing or ameliorating neonatal HSV infection." This patent focuses on innovative approaches to treat or prevent neonatal herpes simplex virus (HSV) infection and its associated neurological and non-neurological sequelae. Another notable patent is for "High affinity B7-H6 antibodies and antibody fragments," which includes antibodies, antigen-binding antibody fragments, chimeric antigen receptors (CARs), and bispecific T cell engagers (BiTEs) that specifically bind to B7 homolog 6. This patent also outlines methods for utilizing these antibodies and the cells that incorporate them.

Career Highlights

Margaret has had a distinguished career, working with esteemed institutions such as Dartmouth College and Duke University. Her research has not only advanced scientific knowledge but has also contributed to practical applications in medicine.

Collaborations

Throughout her career, Margaret has collaborated with notable colleagues, including Casey Hua and Charles L Sentman. These partnerships have fostered an environment of innovation and discovery in her research endeavors.

Conclusion

Margaret Ackerman's work exemplifies the impact of innovative thinking in the biomedical field. Her patents and collaborations highlight her commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…